文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

症状性子宫肌瘤的当前治疗:现有证据与治疗困境

Current treatment for symptomatic uterine fibroids: available evidence and therapeutic dilemmas.
PubMed 文献 · Lancet · 2025-06-19

本综述评估了症状性子宫肌瘤的当前治疗,包括子宫动脉栓塞术、MRI引导高强度聚焦超声、腹腔镜射频消融、经宫颈射频消融、醋酸乌利司他及口服促性腺激素释放激素拮抗剂联合反向添加疗法,并将这些疗法置于IDEAL框架和药物开发临床阶段框架中,指出证据关键缺口如缺乏与标准治疗的頭对頭比较、长期数据稀缺及对真实世界肌瘤和患者特征考虑不足,提供证据强度评估并提出实用流程图以辅助临床决策。

要点

  • 综述评估了子宫动脉栓塞术、MRI引导高强度聚焦超声、腹腔镜与经宫颈射频消融、醋酸乌利司他及口服GnRH拮抗剂联合反向添加疗法。
  • 证据关键缺口包括缺乏与标准治疗的頭对頭比较、长期数据稀缺及对真实世界肌瘤和患者特征考虑不足。
  • 作者提出实用流程图以帮助临床医生在治疗决策中导航,支持共享和充分知情的决策。

核心结论

  • 本综述评估了症状性子宫肌瘤的当前治疗,指出证据关键缺口,并提出实用流程图以辅助临床决策和确定研究议程。

研究设计与样本

  • 本综述将评估的疗法置于IDEAL框架和药物开发临床阶段框架中,并评估现有证据强度。

主要发现

  • 证据关键缺口包括缺乏与标准治疗的頭对頭比较、长期数据稀缺及对真实世界肌瘤和患者特征考虑不足。

临床怎么用

  • 作者提出实用流程图以帮助临床医生在治疗决策中导航,确保为处于不同治疗开发阶段的症状性肌瘤女性提供最佳护理。
  • 作者认为对上述问题的洞察为患者和临床医生提供必要信息,以支持共享和充分知情的决策过程。

局限性

  • 缺乏与标准治疗的頭对頭比较。
  • 长期数据稀缺。
  • 对真实世界肌瘤和患者特征考虑不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This Review offers an evaluation of current treatments for symptomatic uterine fibroids, including uterine artery embolisation, MRI-guided high-intensity focused ultrasound, laparoscopic radiofrequency ablation, transcervical radiofrequency ablation, ulipristal acetate, and oral gonadotropin-releasing hormone antagonists with add-back therapy. Placing these therapies within the IDEAL (Idea, Development, Exploration, Assessment, And Long-Term Follow-Up) framework and the clinical phases of drug development framework, we highlight key gaps in the evidence such as the lack of head-to-head comparisons with standard care, scarce long-term data, and inadequate consideration of real-world fibroid and patient characteristics. We provide a clear overview, assess the strength of the available evidence, and propose a practical flowchart to help clinicians navigate treatment decisions, ensuring the best care for women with symptomatic fibroids at various stages of therapy development. Insight into these matters equips both patient and clinician with essential information to support the process of shared and fully informed decision making. Importantly, this Review also identifies knowledge gaps that contribute to the specification of the fibroid research agenda.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. de Smit NS, de Lange ME, Boomsma MF, et al. Current treatment for symptomatic uterine fibroids: available evidence and therapeutic dilemmas. Lancet. 2025. PMID: 40544858. doi:10.1016/S0140-6736(25)00728-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。